InvestorsHub Logo
icon url

north40000

04/27/20 3:54 PM

#269646 RE: HinduKush #269621

AZN and LLY candidates will likely be more expensive than Vascepa, even with insurance and co-pay. I pay now, with insurance, a sum that Amarin expected in November 2018 I would pay: $9/3 month refill or $36 per year. Do you think either AZN or LLY would come close to $36 per year for their meds—the out of pocket cost to me?
icon url

hamkypamky

04/27/20 9:29 PM

#269698 RE: HinduKush #269621

Astra Zeneca's Farxiga and Lilly's Jardiance coupled with their GLP-1 receptor agonists will BE blockbusters as they are game changers in Heart Failure and CVD



https://www.drugs.com/farxiga.html

Farxiga can cause serious infections in the penis or vagina. Get medical help right away if you have burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, or if you don't feel well.



Taking Farxiga can rot your junk off.

If that isn't a drug-killing side effect, well, competitors aren't marketing hard enough.

Between a safe, proven, minimal side effect drug like Vascepa and my junk falling off, I know which drug I'm taking..